The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its ...

National Biotechnology Conference, gene therapies, bispecific antibodies and other novel modalities—relative newcomers to ...

Precigen on Tuesday said a green light would make PRGN-2012 the only FDA-approved therapeutic for the treatment of adults with the disorder, which is a lifelong neoplastic disease of the upper and ...

The Omaha resident, who has adopted and fostered a number of dogs, had traveled to the shelter hoping to adopt a Japanese ...

YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from the ongoing ...

Miltenyi Biotec, a global leader in cell and gene therapy solutions, has inaugurated India’s first dedicated Cell and Gene Therapy Centre of Excellence the Miltenyi Innovation and Technology Centre ...

Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

Miltenyi Biotec opens cell & gene therapy centre in Genome Valley, advancing innovation in combating diseases like cancer.

The facility features a showroom with MACS instruments, a CliniMACS Prodigy platform for therapy development, and dedicated ...

Regeneron Pharmaceuticals said on Monday its experimental gene therapy showed improved hearing in 10 of 11 children between ...

Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million.

A gene therapy from Regeneron Pharmaceuticals Inc. improved hearing in nearly all deaf children in a clinical trial, results ...